Research
PT-141 Bremelanotide Research: Melanocortin & CNS Studies
"PT-141 acts centrally via MC3R and MC4R receptors rather than through vascular mechanisms. A published overview of bremelanotide melanocortin receptor research."
PT-141 (Bremelanotide) is a cyclic peptide analogue of alpha-MSH that acts on central melanocortin receptors (MC3R and MC4R) rather than through vascular mechanisms. Research has examined its CNS-mediated effects, receptor binding pharmacology and downstream signalling in research models. Unlike PDE5 inhibitors that act peripherally, PT-141's central mechanism of action has been a focus of scientific interest in sexual function research.
⚠️ Research Disclaimer: All information in this article relates to scientific research only. UK Peptides compounds are sold strictly for laboratory and in vitro research use. This content does not constitute medical advice. All products are not for human consumption.
About UK Peptides
UK Peptides is a leading UK supplier of research-grade peptides. All compounds are HPLC verified at 99%+ purity with COA documentation. Based in Leeds, UK — supplying researchers across the United Kingdom.
Browse Research Compounds →